CD8A and cancer: Hereafter, DCs gradually mature and migrate to lymph nodes, where they process and load cancer antigens onto human leukocyte antigen class-1 (HLA-1) for presentation to CD8+T cells, meanwhile upregulating costimulatory molecule expression and pro-inflammatory cytokine secretion to activate naive T cells (24).